GlobeNewswire by notified

Anmodning om ophævelse af suspension af afdelinger i Investeringsforeningen Nordea Invest


De tekniske problemer er nu løst og det er igen muligt at stille priser for nedenstående afdelinger, hvorfor handelen med nedenstående afdelinger genoptages.

Short nameNavnISIN
NDINSCKL1 Nordea Invest Nordic Small Cap KL 1 DK0015974695
NDIESCSKL1 Nordea Invest European Small Cap Stars KL 1 DK0015960983
NDIDKKL1 Nordea Invest Danmark KL 1 DK0010265859
NDIGSCKL1 Nordea Invest Global Small Cap KL 1 DK0016050974
NDIEUSTKL1 Nordea Invest European Stars KL 1 DK0010265693
NDINASTKL1 Nordea Invest North American Stars KL 1 DK0010265776
NDIGUAKL1 Nordea Invest Globale UdbytteAktier KL 1 DK0010265503
NDIGOBLKL1 Nordea Invest Globale obligationer KL 1 DK0010170398
NDIMLOKL1 Nordea Invest Mellemlange obligationer KL 1 DK0015168686
NDIAKTIIKL1 Nordea Invest Aktier II KL 1 DK0015357065
NDIEHYKL1 Nordea Invest European HYB KL 1 DK0016306798
NDIDAFKL1 Nordea Invest Danske aktier fokus KL 1 DK0060012466
NDIAKL1 Nordea Invest Aktier KL 1 DK0010250158
NDIVOBKL1 Nordea Invest Virksomhedsobligationer KL 1 DK0016015399
NDIVOHKL1 Nordea Invest Virksomhedsobli. Højrente KL1 DK0016067432
NDIHOJLKL1 Nordea Invest HøjrenteLande KL 1 DK0016254899
NDIGSTKL1 Nordea Invest Global Stars KL 1 DK0010301324
NDIEMKL1 Nordea Invest Emerging Markets KL 1 DK0010308170
NDIKOLKL1 Nordea Invest Korte obligationer Lagerbeskattet KL 1 DK0060014678
NDISTABKL1 Nordea Invest Stabil Balanceret KL 1 DK0060014595
NDISTABAKL1 Nordea Invest Stabile Aktier KL 1 DK0060048304
NDINOSKL1 Nordea Invest Nordic Stars KL 1 DK0060095735
NDISTAAKL1 Nordea Invest Stabile Aktier Akkumulerende KL 1 DK0060096030
NDI4KL1 Nordea Invest Basis 4 KL 1 DK0060075893
NDIB1KL1 Nordea Invest Basis 1 KL 1 DK0016195860
NDIB2KL1 Nordea Invest Basis 2 KL 1 DK0016195944
NDIB3KL1 Nordea Invest Basis 3 KL 1 DK0016196082
NDIKMKL1 Nordea Invest Klima og Miljø KL 1 DK0060192185
NDIGAIKL1 Nordea Invest Globale Aktier Indeks KL 1 DK0060451623
NDIESKL1 Nordea Invest Emerging Stars KL 1 DK0060586394
NDINAEKL1 Nordea Invest North America Enhanced KL 1 DK0060831451
NDIGLENHKL1 Nordea Invest Global Enhanced KL 1 DK0060949881
NDIEUENHKL1 Nordea Invest Europe Enhanced KL 1 DK0060949964
NDIJAPENHKL1 Nordea Invest Japan Enhanced KL 1 DK0060950038
NDIEMMAENKL1 Nordea Invest Emerging Markets Enhanced KL 1 DK0060950111
NDIGSEKL1 Nordea Invest Global Small Cap Enhanced KL 1 DK0061112893
NDIBAKL1 Nordea Invest Bæredygtige Aktier KL 1 DK0061116027
NDIBOKL1 Nordea Invest Bæredygtige Obligationer KL 1 DK0061139748
NDIFONKL1 Nordea Invest Fonde KL 1 DK0060145183
NDIKOKL1 Nordea Invest Korte obligationer KL 1 DK0060268506
NDIVOMKL1 Nordea Invest Verdens Obligationsmarkeder KL 1 DK0060353886
NDILAOKL1 Nordea Invest Lange Obligationer KL 1 DK0060187342

Med venlig hilsen
Nordea Invest

Tom Holflod
Senior Product Manager

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Sai Life Sciences reaffirms commitment to Sustainability, charts out SDGs to be achieved by FY276.6.2023 12:41:52 CEST | Press release

HYDERABAD, India, June 06, 2023 (GLOBE NEWSWIRE) -- On the World Environment Day 2023, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced its renewed Sustainable Development Goals (SDG) charting out the roadmap to achieve specific environmental, social and governance (ESG) targets by the financial year ending March 31, 2027. Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, “Our renewed Sustainable Development Goals reflect a coming of age of our Sustainability journey. The learnings and successes from the first edition have shaped our aspiration for this phase and signify a certain boldness that comes with persevering unabated on a chosen path. While Sustainability has always been at the heart of our ethos at Sai Life Sciences, I must thank all our customers and partners for inspiring us raise the bar each day.” Sai Life Sciences first charted out its SDGs in 2019 with a three-year ti

Calibre Announces the Publication of its 2022 Sustainability Report, Demonstrating Commitment to Transparency and Responsible Practices6.6.2023 12:00:55 CEST | Press release

VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased to announce the publication of its 2022 Sustainability Report (“the Report”). The Report outlines Calibre’s 2022 progress and achievements, provides guidance for the Company’s Environmental, Social and Governance (“ESG”) performance, and underscores Calibre’s unwavering commitment to transparency, accountability and responsible business practices. Calibre acknowledges that incorporating sustainability into its business strategy is essential to our long-term success. In 2022, the Company saw record production for the third consecutive year. Calibre’s increasing focus on sustainability practices and robust ESG performance ensures that such accomplishments are achieved in ways that are ethical, transparent, accountable, and respectful of the rights of others. Darren Hall, President and Chief Executive Officer, stated: “At Calibre, we recogniz

Noted Vaccine Researcher Thomas P. Monath Awarded Sabin’s Gold Medal; Cameroon Physician Sangwe Clovis Nchinjoh Receives Rising Star Award6.6.2023 12:00:00 CEST | Press release

WASHINGTON, June 06, 2023 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today awarded the 30th Albert B. Sabin Gold Medal Award to Thomas P. Monath, MD, and its Rising Star Award to Sangwe Clovis Nchinjoh, MD, MPH, in a ceremony at Washington D.C.’s National Academy of Sciences building. Dr. Monath was selected for the Gold Medal for his more than four decades of commitment to advancing knowledge of arboviruses and vaccine research and development (R&D) that contributed to the development of several innovative vaccines including those for Ebola Zaire, smallpox, dengue, Japanese encephalitis and West Nile. The Gold Medal, celebrating three decades of recognition, is Sabin’s highest scientific honor. It is given annually to a distinguished member of the global health community who has made exceptional contributions to vaccinology or a complementary field. Past award recipients include leaders of vaccinology and vaccine advocacy such as Drs. Barney Graham, Carol Baker, Bill Foege, Anne

PRESS RELEASE: SSH launches OpenSSH support service for multi-platform SSH environments6.6.2023 12:00:00 CEST | Press release

Helsinki, Finland - June 6, 2023 - To resolve various customer support problems regarding OpenSSH implementations, SSH has launched a support service for OpenSSH. As a result, customers benefit from high-quality SSH support services also for the open-source variant of SSH software. OpenSSH will be supported on Windows and Red Hat Linux platforms. The SSH protocol is a secure network protocol used to establish encrypted and secure remote connections and transfer data between different systems. OpenSSH is an open-source implementation of the SSH protocol. It was initially released as a free version of SSH’s Tectia product. As an open-source product, OpenSSH is popular, especially as SSH client software. However, its usage in critical corporate environments has been partly limited due to a lack of high-quality support services or support from a single source for all SSH clients. Without proper support services, customers often invest in in-house OpenSSH expertise, resulting in increased o

Novo Nordisk A/S – Share repurchase programme6.6.2023 11:56:26 CEST | Press release

Bagsværd, Denmark, 6June 2023 – On 9 May 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under the programme initiated 9 May 2023, Novo Nordisk will repurchase B shares for an amount up to DKK 5.8 billion in the period from 10 May 2023 to 8 August 2023. Since the announcement 30 May of the programme, the following transactions have been made: Number of B sharesAverage purchase priceTransaction value, DKKAccumulated, last announcement906,0001,042,810,01330 May 202382,7001,123.3192,897,99931 May 202385,0001,117.9295,023,0001 June 202385,0001,109.7994,332,2702 June 202390,0001,076.5596,889,206Accumulated under the